Acquisition of BioBridges Announced by The Adecco Group
BioBridges Joins Global Pharmaceutical Services Leader
BioBridges, a renowned Career Portfolio® Management company based outside Boston, has been acquired by the world's leading workforce solutions provider, expanding its reach and resources in the pharmaceutical and life sciences sector.
Founded in 2005, BioBridges specializes in clinical development services for emerging and established pharmaceutical, biotechnology, and medical device companies. Its proprietary and scalable Career Portfolio® Management model has been successfully applied in collaborations with over 500 companies, serving a national client base in the U.S. [1]
This innovative approach allows BioBridges to provide clinical trial support tailored to the specific requirements of its clients’ programs. The company’s expertise spans multiple areas within clinical development, supporting drug and device development from early discovery through commercialization. [1][3]
The acquisition, which took place in 2017, positioned BioBridges as part of a diversified pharmaceutical and life sciences services platform focused on discovery, development, and commercialization solutions across the drug life cycle. The parent company's broad portfolio includes services spanning various therapeutic areas and markets, leveraging BioBridges’ clinical development expertise as part of its comprehensive offerings. [1]
Following the acquisition, BioBridges will come under the leadership of David Alexander, president of the parent company's North America Finance, Office, and Healthcare businesses. Jeff Souza, currently CEO of BioBridges, will take on the new role of Senior Vice President of Client Services. Cindy Steinberg, founding partner, will continue as a consultant to the company through the transition. Jason Falchuk, founding partner and president of BioBridges, will remain in his current role. [1]
The parent company, headquartered in Zurich, Switzerland, is a Fortune Global 500 company and operates in 60 countries and territories. It offers total workforce solutions including temporary staffing, permanent placement, career transition, talent development, and outsourcing, making it the world's leading provider of workforce solutions. [2]
The terms of the transaction have not been disclosed.
BioBridges, respected in the life sciences arena, manages the careers of professionals with extensive experience in the biotech, pharmaceutical, and medical device industries. With over 33,000 FTE employees worldwide and providing career opportunities to over 1 million people annually, the acquisition is set to strengthen the parent company's position in the pharmaceutical and life sciences sector. The company's mission, to transform the world of work through talent and technology, aligns well with BioBridges' focus on innovative career management and clinical development services. [1][3]
[1] BioBridges. (2021). About Us. https://www.biobridges.com/about-us/ [2] ManpowerGroup. (2021). About Us. https://www.manpowergroup.com/about-us/ [3] BioBridges. (2021). Services. https://www.biobridges.com/services/
Read also:
- Rapid Expansion in Organic Rice Protein Market Projected at 15.6% Through 2034
- Kenya broadens economic zones featuring Olkaria's geothermal energy advantage
- Century Lithium Announces Production of Battery-Grade Lithium Metal Anodes from Angel Island Lithium Carbonate
- Truck manufacturers directed to cease enforcing immediate limp mode for low DEF emission regulations, according to EPA.
